Evolution of adrenoleukodystrophy model systems
Open Access
- 29 December 2020
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 44 (3), 544-553
- https://doi.org/10.1002/jimd.12357
Abstract
X‐linked adrenoleukodystrophy (ALD) is a neurometabolic disorder affecting the adrenal glands, testes, spinal cord and brain. The disease is caused by mutations in the ABCD1 gene resulting in a defect in peroxisomal degradation of very long‐chain fatty acids and their accumulation in plasma and tissues. Males with ALD have a near 100% life‐time risk to develop myelopathy. The life‐time prevalence to develop progressive cerebral white matter lesions (known as cerebral ALD) is about 60%. Adrenal insufficiency occurs in about 80% of male patients. In adulthood, 80% of women with ALD also develop myelopathy, but adrenal insufficiency or cerebral ALD are very rare. The complex clinical presentation and the absence of a genotype‐phenotype correlation are complicating our understanding of the disease. In an attempt to understand the pathophysiology of ALD various model systems have been developed. While these model systems share the basic genetics and biochemistry of ALD they fail to fully recapitulate the complex neurodegenerative etiology of ALD. Each model system recapitulates certain aspects of the disorder. This exposes the complexity of ALD and therefore the challenge to create a comprehensive model system to fully understand ALD. In this review, we provide an overview of the different ALD modeling strategies from single‐celled to multicellular organisms and from in vitro to in vivo approaches, and introduce how emerging iPSC‐derived technologies could improve the understanding of this highly complex disorder.Funding Information
- Association Européenne contre les Leucodystrophies (2019‐020C2)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.196.310)
This publication has 83 references indexed in Scilit:
- The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesisStem Cell Research & Therapy, 2012
- Bezafibrate lowers very long‐chain fatty acids in X‐linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongationJournal of Inherited Metabolic Disease, 2012
- Oxidative Damage Compromises Energy Metabolism in the Axonal Degeneration Mouse Model of X-AdrenoleukodystrophyAntioxidants and Redox Signaling, 2011
- Antioxidants halt axonal degeneration in a mouse model of X‐adrenoleukodystrophyAnnals of Neurology, 2011
- Induced pluripotent stem cell models from X‐linked adrenoleukodystrophy patientsAnnals of Neurology, 2011
- The role of ELOVL1 in very long‐chain fatty acid homeostasis and X‐linked adrenoleukodystrophyEMBO Molecular Medicine, 2010
- Live Cell FRET MicroscopyOnline Journal of Public Health Informatics, 2007
- The COMATOSE ATP-Binding Cassette Transporter Is Required for Full Fertility in ArabidopsisPlant Physiology, 2007
- Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophyHuman Molecular Genetics, 2005
- Adrenoleukodystrophy: Impaired oxidation of long chain fatty acids in cultured skin fibroblasts and adrenal cortexBiochemical and Biophysical Research Communications, 1981